Bristol Myers Squibb Presents Landmark 10-12 months Observe-Up Information from CheckMate -067 Which Confirmed Continued Sturdy Lengthy-Time period Survival Profit with Opdivo ® plus Yervoy ® in Superior Melanoma By Investing.com
These information signify the longest reported median total survival from a Part…
Myers Industries Broadcasts Reporting Date and Convention Name for 2024 Second Quarter Outcomes By Investing.com
AKRON, Ohio--(BUSINESS WIRE)--Myers Industries, Inc. (NYSE: MYE) as we speak introduced that…
